XT
ENSC icon

XTX Topco’s Ensysce Biosciences ENSC Stock Holding History

XTX Topco’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1K Buy
+24,363
New +$15.4K ﹤0.01% 3640
2025
Q4 		– Sell
-10,957
Closed -$26K – 3431
2025
Q3 		$26K Buy
+10,957
New +$23.6K ﹤0.01% 2281
2024
Q3 		– Sell
-882
Closed -$6.7K – 2219
2024
Q2 		$6.7K Buy
+882
New +$8.04K ﹤0.01% 1728

Other funds holding ENSC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $163M AUM 18.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's ENSC Position: Q1 2026 in Review

XTX Topco opened a new position in Ensysce Biosciences (ENSC) in Q1 2026: 24,363 shares worth $13.1K. The stake represents ﹤0.01% of the portfolio and ranks #3640 among its holdings. This is a return to the name: XTX Topco previously reported a position in ENSC as recently as Q3 2025.

XTX Topco first reported a position in ENSC in Q2 2024 and has held it in 3 quarters since. The position peaked at $26K in Q3 2025. 15 funds tracked by Wall St. Rank hold ENSC as of Q1 2026.

  • XTX Topco held 24,363 shares of Ensysce Biosciences worth $13.1K as of Q1 2026.
  • Ensysce Biosciences was a new XTX Topco position in Q1 2026.
  • Ensysce Biosciences made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3640 holding.
  • XTX Topco first reported a position in Ensysce Biosciences in Q2 2024 and has held it in 3 quarters since.
  • XTX Topco's Ensysce Biosciences position peaked at $26K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.